Vaxart Inc to Host Investor Q&A Webcast Transcript
Greetings, and welcome to the Vaxart investor Q&A webcast. (Operator Instructions). A question-and-answer session will follow management's opening remarks. As a reminder, this conference is being recorded.
I will now like to turn the conference over to your host, Brant Biehn, Senior Vice President, Business Operations.
Good day, everyone, and welcome to today's call. Joining us from Vaxart are Andrei Floroiu, the Chief Executive Officer; Dr. Sean Tucker, our Founder and Senior Vice President and Chief Scientific Officer; and Dr. James Cummings, our Chief Medical Officer.
But before we get started, I'd like to remind everyone during this conference call that Vaxart may make forward-looking statements, including statements about the company's financial results, financial guidance, its future business strategies and operations and its product development and regulatory progress, including statements about its ongoing or planned clinical trials.
Actual results could differ
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |